Column: Eli Lilly is slashing insulin prices, but hold your applause

México Noticias Noticias

Column: Eli Lilly is slashing insulin prices, but hold your applause
México Últimas Noticias,México Titulares
  • 📰 latimes
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 82%

Eli Lilly's price cuts on insulin will increase its profits, thanks to America's bizarre drug pricing system. Don't mistake its move for philanthropy.

They’re the victims of an enormous run-up in drugmakers’ insulin prices over the last 30 to 40 years. These prices fall into two categories: The list prices, which in the U.S. can currently run to more than $200 per vial, and the out-of-pocket price.Few patients consistently pay the list price, however. Most are charged only a co-pay by their health plan or even receive insulin at no charge through Medicaid.

Insulin has become the “poster child for runaway incentives for higher list prices,” as Mulcahy puts it, for several reasons. Nevertheless, observes Robin Feldman, an expert on pharmaceutical law at the University of California College of the Law, the changes allow drugmakers to extend their marketing rights.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

latimes /  🏆 11. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Sanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo NordiskSanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo NordiskThe French drugmaker is the last major insulin manufacturer to try to head off government efforts to cap monthly costs by announcing its own steep price cuts.
Leer más »

Sanofi is the latest insulin maker to announce price capSanofi is the latest insulin maker to announce price capSanofi joins Eli Lilly and Novo Nordisk to cap insulin prices. President Joe Biden still wants Congress to enact limits. MORE ⬇️
Leer más »

Why the Music Industry Must Embrace Meritocracy for True Diversity, Inclusion (Guest Column)Why the Music Industry Must Embrace Meritocracy for True Diversity, Inclusion (Guest Column)For far too long, the music industry has perpetuated a system that benefits a select few at the expense of marginalized communities.
Leer más »

Column: Harvey Historical Society wants transit agencies to fix ugly design of proposed transportation centerColumn: Harvey Historical Society wants transit agencies to fix ugly design of proposed transportation centerIf the Harvey Transportation Center is built as designed, it would be a tremendous missed economic development opportunity to highlight the community’s rich past and enormous potential, writes Ted Slowik.
Leer más »

Tim Steller's column: Burden on Tucson, other cities to confront housing shortageTim Steller's column: Burden on Tucson, other cities to confront housing shortageFor Star subscribers: A legislative proposal to override zoning laws in Arizona's cities appears dead, but the problem of inadequate housing persists. Tucson's guest-house program shows the city should move faster.
Leer más »

Courtney Love Writes Column Excoriating Rock and Roll Hall of Fame, Then Edits Her EditorCourtney Love Writes Column Excoriating Rock and Roll Hall of Fame, Then Edits Her EditorLove said the Guardian 'censored' a particularly bold line in her piece—which still told the institution to 'go to hell in a handbag' over its gender disparity.
Leer más »



Render Time: 2025-03-01 22:33:00